Stat3/Stat5 Signaling Antibody Sampler Kit #67088
Product Information
Kit Usage Information
Protocols
- 3230: Western Blotting, Immunoprecipitation (Agarose), Immunohistochemistry (Paraffin)
- 4322: Western Blotting, Immunofluorescence*, Flow Cytometry, BSA-free Methanol Permeabilization Protocol
- 4406: Western Blotting
- 7074: Western Blotting
- 9145: Western Blotting, Immunoprecipitation (Agarose), Immunohistochemistry (Leica® Bond™), Immunohistochemistry (Paraffin), Immunofluorescence*, Flow, Sonication Chromatin Immunoprecipitation Protocol, Sonication Chromatin Immunoprecipitation
- 12640: Western Blotting, Immunoprecipitation (Agarose), Immunofluorescence*, Flow, ChIP Magnetic, Chromatin IP-seq
- 94205: Western Blotting, Immunoprecipitation (Agarose), ChIP Magnetic
Product Description
Background
In the context of hematopoiesis, Stat3 and Stat5 may act antagonistically (12,13). Stat3 activity can promote differentiation of myeloid progenitor cells into neutrophils in a granulocyte colony-stimulating factor (G-CSF)-dependent manner, while Stat5 activation results in inhibition of this pathway in a granulocyte-macrophage colony-stimulating factor (GM-CSF)-dependent manner (13). Stat5 activity upregulates SOCS3, which subsequently inhibits Stat3 and results in differentiation to monocytes and macrophages (13). In addition to their roles in regulating gene expression as transcription factors, Stat3 and Stat5 are also capable of altering chromatin landscapes through recruitment of chromatin remodeling enzymes (14,15). While they serve many key functions in normal growth and development, if disrupted, the Jak2/Stat3 and Jak2/Stat5 signaling axes contribute to various diseases, including many types of cancer, non-alcoholic fatty liver disease, and eosinophilic cellulitis (16-20).
- Darnell Jr., J. et al. (1994) Science 264, 1415-1421.
- Leonard, W.J. and O'Shea, J.J. (1998) Annu. Rev. Immunol. 16, 293-322.
- Caldenhoven, E. et al. (1996) J. Biol. Chem. 271, 13221-13227.
- Wen, Z. et al. (1995) Cell 82, 241-250.
- Yokogami, K. et al. (2000) Curr. Biol. 10, 47-50.
- Lim, C.P. and Cao, X. (1999) J. Biol. Chem. 274, 31055-31061.
- Bromberg, J. F. et al. (1999) Cell 98, 295-303.
- Su, L. et al. (1999) J. Biol. Chem. 274, 31770-31774.
- Dentelli, P. et al. (1999) J. Immunol. 163, 2151-2159.
- Cattaneo, E. et al. (1999) Trends Neurosci. 22, 365-369.
- Frank, D.A. (1999) Mol. Med. 5, 432-456.
- Cohen, P.A. et al. (2008) Blood 112, 1832-43.
- Zhang, M. et al. (2023) Cell Death Discov. 9, 274.
- Wingelhofer, B. et al. (2018) Leukemia 32, 1713-1726.
- Orlova, A. et al. (2019) Cancers (Basel) 11, 1930.
- Warsch, W. et al. (2013) Blood 122, 2167-75.
- Halim, C.E. et al. (2020) Biomedicines 8, 316.
- Huang, B. et al. (2022) Front. Oncol. 12, 1023177.
- Kaltenecker, D. et al. (2019) Cytokine 124, 154569.
- Morot, J. et al. (2023) JAMA Dermatol. 159, 820-829.
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.